Unknown

Dataset Information

0

Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma.


ABSTRACT: Background and objectives: Cancer coagulopathy is thought to be partially due to the up-regulation of tissue factor (TF), thrombin-antithrombin complex (TAT) and soluble P-selectin (sP-selectin). The purpose of this study was to evaluate the clinical significance of TF, TAT and sP-selectin in patients with pancreatic cancer. Materials and methods: The study included 93 subjects: 73 newly diagnosed patients with pancreatic adenocarcinoma (42 with stage I-III and 31 with metastatic cancer (stage IV)) and a control group of 20 healthy subjects. Analyzed patients were hospitalized in the Department of Digestive Tract Diseases, Medical University of Lodz or in the Department of Digestive Tract Surgery, Silesian University, Katowice, Poland. All laboratory parameters were measured using ELISA procedures. Results: TF plasma levels were detectable in all patients and were significantly higher in metastatic cancer compared to stage I-III patients and the control group (p < 0.05). In patients with pancreatic adenocarcinoma, the median levels of TAT were also elevated compared to the control group. Moreover, patients with metastases had significantly higher TAT concentration compared to the I-III cancer group. On the other hand, only the metastatic patients group showed significantly higher plasma sP-selectin levels compared to the controls (p = 0.009), whereas there was no difference between localized and metastatic cancer patients. Conclusions: The coagulation disorders are present in the majority of patients with pancreatic adenocarcinoma already at the diagnosis stage and reflect cancer progression and spread.

SUBMITTER: Talar-Wojnarowska R 

PROVIDER: S-EPMC7763230 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma.

Talar-Wojnarowska Renata R   Woźniak Małgorzata M   Borkowska Anna A   Cypryk Katarzyna K   Olakowski Marek M   Małecka-Panas Ewa E  

Medicina (Kaunas, Lithuania) 20201209 12


<i>Background and objectives</i>: Cancer coagulopathy is thought to be partially due to the up-regulation of tissue factor (TF), thrombin-antithrombin complex (TAT) and soluble P-selectin (sP-selectin). The purpose of this study was to evaluate the clinical significance of TF, TAT and sP-selectin in patients with pancreatic cancer. <i>Materials and methods:</i> The study included 93 subjects: 73 newly diagnosed patients with pancreatic adenocarcinoma (42 with stage I-III and 31 with metastatic c  ...[more]

Similar Datasets

2023-12-18 | GSE239721 | GEO
| S-EPMC7771868 | biostudies-literature
| S-EPMC5504321 | biostudies-literature
2024-07-17 | GSE267013 | GEO
2014-12-23 | GSE58133 | GEO
2022-04-20 | GSE193729 | GEO
| S-EPMC4871582 | biostudies-literature
2014-12-23 | E-GEOD-58133 | biostudies-arrayexpress
2011-06-06 | GSE27560 | GEO
2020-09-03 | GSE157324 | GEO